Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

Inclusion Criteria: * Subjects with HbeAg Chronic Hepatitis B for at least six months starting from the Screening visit * Subjects with HBsAg-Positive diagnosed at the screening visit * Subjects with HBeAg-Positive or HBeAg-negative diagnosed at the screening visit * For those who were diagnosed HBeAg-Positive, HBV DNA level should be equal or more than 1x10\^5 copies/ml * For those who were diagnosed HBeAg-Negative, HBV DNA level should be equal or more than 1x10\^5 copies/ml * Subjects who were NOT administrated any anti-viral agents including interferon or pegylated interferon Exclusion Criteria: * Subjects with HCV, HDV or HIV * Subjects with decompensated liver disease who have more than 2.5mg/dl of total bilirubin, longer than 3 seconds of prothrombin time, less than 30g/l of serum albumin * With medical history of hemorrhage, hepatic encephalopathy, or dyshepatia due to ascites, jaundice, varicose vein * Less than 50ml/min of creatinine clearance diagnosed at the screening visit * More than 50 ng/ml of alpha-fetoprotein at the screening visit * Involved in other studies